Device Related Infection
7
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
The IVCare Adaptive Platform Trial
Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial
Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study
Project My Heart Your Heart: Pacemaker Reuse
Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device
Antithrombotic Therapy in Patients Undergoing CIED Surgery - HEMATOMA NO MORE Registry